Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 1/2014

01-02-2014 | Correspondence

Antifungal prophylaxis following allogeneic haematopoietic stem cell transplantation: what is the role of voriconazole?

Authors: M. Hoenigl, K. Seeber, R. Krause

Published in: Infection | Issue 1/2014

Login to get access

Excerpt

To the Editor, …
Literature
1.
Hicheri Y, Cook G, Cordonnier C. Antifungal prophylaxis in haematology patients: the role of voriconazole. Clin Microbiol Infect. 2012;18:1–15.PubMedCrossRef
2.
Marks DI, Pagliuca A, Kibbler CC, et al. Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation. Br J Haematol. 2011;155:318–27.PubMedCentralPubMedCrossRef
3.
Marr KA, Crippa F, Leisenring W, et al. Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants. Blood. 2004;103:1527–33.PubMedCrossRef
4.
Hoenigl M, Salzer HJ, Raggam RB, et al. Impact of galactomannan testing on the prevalence of invasive aspergillosis in patients with hematological malignancies. Med Mycol. 2012;50:266–9.PubMedCrossRef
5.
Hoenigl M, Duettmann W, Raggam RB, et al. Potential factors for inadequate voriconazole plasma concentrations in intensive care unit patients and patients with hematological malignancies. Antimicrob Agents Chemother. 2013;57:3262–7.PubMedCentralPubMedCrossRef
Metadata
Title
Antifungal prophylaxis following allogeneic haematopoietic stem cell transplantation: what is the role of voriconazole?
Authors
M. Hoenigl
K. Seeber
R. Krause
Publication date
01-02-2014
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 1/2014
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-013-0562-4

Other articles of this Issue 1/2014

Infection 1/2014 Go to the issue

Clinical and Epidemiological Study

Causes of death in HIV-infected patients from the Cologne–Bonn cohort

Brief Report

Childhood tuberculosis in Lambaréné, Gabon: tuberculosis control in its infancy?

Clinical and Epidemiological Study

Trauma is associated with a better prognosis in intensive care patients with Acinetobacter infections

Case Report

Unilateral mydriasis as the primary sign of neurosyphilis

Clinical and Epidemiological Study

Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group

Brief Report

Reduction of central venous line-associated bloodstream infection rates by using a chlorhexidine-containing dressing

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits